Cargando…
Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta‐analysis
OBJECTIVE: Hypertensive disorders affect 3–10% of pregnancies. Delayed delivery carries maternal risks, while early delivery increases fetal risk, so appropriate timing is important. The aim of this study was to compare immediate delivery with expectant management for prevention of adverse maternal...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594064/ https://www.ncbi.nlm.nih.gov/pubmed/30697855 http://dx.doi.org/10.1002/uog.20224 |
_version_ | 1783430181202952192 |
---|---|
author | Bernardes, T. P. Zwertbroek, E. F. Broekhuijsen, K. Koopmans, C. Boers, K. Owens, M. Thornton, J. van Pampus, M. G. Scherjon, S. A. Wallace, K. Langenveld, J. van den Berg, P. P. Franssen, M. T. M. Mol, B. W. J. Groen, H. |
author_facet | Bernardes, T. P. Zwertbroek, E. F. Broekhuijsen, K. Koopmans, C. Boers, K. Owens, M. Thornton, J. van Pampus, M. G. Scherjon, S. A. Wallace, K. Langenveld, J. van den Berg, P. P. Franssen, M. T. M. Mol, B. W. J. Groen, H. |
author_sort | Bernardes, T. P. |
collection | PubMed |
description | OBJECTIVE: Hypertensive disorders affect 3–10% of pregnancies. Delayed delivery carries maternal risks, while early delivery increases fetal risk, so appropriate timing is important. The aim of this study was to compare immediate delivery with expectant management for prevention of adverse maternal and neonatal outcomes in women with hypertensive disease in pregnancy. METHODS: CENTRAL, PubMed, MEDLINE and ClinicalTrials.gov were searched for randomized controlled trials comparing immediate delivery to expectant management in women presenting with gestational hypertension or pre‐eclampsia without severe features from 34 weeks of gestation. The primary neonatal outcome was respiratory distress syndrome (RDS) and the primary maternal outcome was a composite of HELLP syndrome and eclampsia. The PRISMA‐IPD guideline was followed and a two‐stage meta‐analysis approach was used. Relative risks (RR) and numbers needed to treat or harm (NNT/NNH) with 95% CI were calculated to evaluate the effect of the intervention. RESULTS: Main outcomes were available for 1724 eligible women. Compared with expectant management, immediate delivery reduced the composite risk of HELLP syndrome and eclampsia in all women (0.8% vs 2.8%; RR, 0.33 (95% CI, 0.15–0.73); I (2) = 0%; NNT, 51 (95% CI, 31.1–139.3)) as well as in the pre‐eclampsia subgroup (1.1% vs 3.5%; RR, 0.39 (95% CI, 0.15–0.98); I (2) = 0%). Immediate delivery increased RDS risk (3.4% vs 1.6%; RR, 1.94 (95% CI 1.05–3.6); I (2) = 24%; NNH, 58 (95% CI, 31.1–363.1)), but depended upon gestational age. Immediate delivery in the 35(th) week of gestation increased RDS risk (5.1% vs 0.6%; RR, 5.5 (95% CI, 1.0–29.6); I (2) = 0%), but immediate delivery in the 36(th) week did not (1.5% vs 0.4%; RR, 3.4 (95% CI, 0.4–30.3); I (2) not applicable). CONCLUSION: In women with hypertension in pregnancy, immediate delivery reduces the risk of maternal complications, whilst the effect on the neonate depends on gestational age. Specifically, women with a‐priori higher risk of progression to HELLP, such as those already presenting with pre‐eclampsia instead of gestational hypertension, were shown to benefit from earlier delivery. © 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology. |
format | Online Article Text |
id | pubmed-6594064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley & Sons, Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65940642019-07-10 Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta‐analysis Bernardes, T. P. Zwertbroek, E. F. Broekhuijsen, K. Koopmans, C. Boers, K. Owens, M. Thornton, J. van Pampus, M. G. Scherjon, S. A. Wallace, K. Langenveld, J. van den Berg, P. P. Franssen, M. T. M. Mol, B. W. J. Groen, H. Ultrasound Obstet Gynecol Systematic Reviews OBJECTIVE: Hypertensive disorders affect 3–10% of pregnancies. Delayed delivery carries maternal risks, while early delivery increases fetal risk, so appropriate timing is important. The aim of this study was to compare immediate delivery with expectant management for prevention of adverse maternal and neonatal outcomes in women with hypertensive disease in pregnancy. METHODS: CENTRAL, PubMed, MEDLINE and ClinicalTrials.gov were searched for randomized controlled trials comparing immediate delivery to expectant management in women presenting with gestational hypertension or pre‐eclampsia without severe features from 34 weeks of gestation. The primary neonatal outcome was respiratory distress syndrome (RDS) and the primary maternal outcome was a composite of HELLP syndrome and eclampsia. The PRISMA‐IPD guideline was followed and a two‐stage meta‐analysis approach was used. Relative risks (RR) and numbers needed to treat or harm (NNT/NNH) with 95% CI were calculated to evaluate the effect of the intervention. RESULTS: Main outcomes were available for 1724 eligible women. Compared with expectant management, immediate delivery reduced the composite risk of HELLP syndrome and eclampsia in all women (0.8% vs 2.8%; RR, 0.33 (95% CI, 0.15–0.73); I (2) = 0%; NNT, 51 (95% CI, 31.1–139.3)) as well as in the pre‐eclampsia subgroup (1.1% vs 3.5%; RR, 0.39 (95% CI, 0.15–0.98); I (2) = 0%). Immediate delivery increased RDS risk (3.4% vs 1.6%; RR, 1.94 (95% CI 1.05–3.6); I (2) = 24%; NNH, 58 (95% CI, 31.1–363.1)), but depended upon gestational age. Immediate delivery in the 35(th) week of gestation increased RDS risk (5.1% vs 0.6%; RR, 5.5 (95% CI, 1.0–29.6); I (2) = 0%), but immediate delivery in the 36(th) week did not (1.5% vs 0.4%; RR, 3.4 (95% CI, 0.4–30.3); I (2) not applicable). CONCLUSION: In women with hypertension in pregnancy, immediate delivery reduces the risk of maternal complications, whilst the effect on the neonate depends on gestational age. Specifically, women with a‐priori higher risk of progression to HELLP, such as those already presenting with pre‐eclampsia instead of gestational hypertension, were shown to benefit from earlier delivery. © 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology. John Wiley & Sons, Ltd. 2019-04-02 2019-04 /pmc/articles/PMC6594064/ /pubmed/30697855 http://dx.doi.org/10.1002/uog.20224 Text en © 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Systematic Reviews Bernardes, T. P. Zwertbroek, E. F. Broekhuijsen, K. Koopmans, C. Boers, K. Owens, M. Thornton, J. van Pampus, M. G. Scherjon, S. A. Wallace, K. Langenveld, J. van den Berg, P. P. Franssen, M. T. M. Mol, B. W. J. Groen, H. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta‐analysis |
title | Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta‐analysis |
title_full | Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta‐analysis |
title_fullStr | Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta‐analysis |
title_full_unstemmed | Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta‐analysis |
title_short | Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta‐analysis |
title_sort | delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta‐analysis |
topic | Systematic Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594064/ https://www.ncbi.nlm.nih.gov/pubmed/30697855 http://dx.doi.org/10.1002/uog.20224 |
work_keys_str_mv | AT bernardestp deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT zwertbroekef deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT broekhuijsenk deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT koopmansc deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT boersk deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT owensm deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT thorntonj deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT vanpampusmg deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT scherjonsa deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT wallacek deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT langenveldj deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT vandenbergpp deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT franssenmtm deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT molbwj deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis AT groenh deliveryorexpectantmanagementforpreventionofadversematernalandneonataloutcomesinhypertensivedisordersofpregnancyanindividualparticipantdatametaanalysis |